Article · 10 Jun 2026
Research articlePublished 2015
Differentiating between Patients with Alzheimer's Disease and Patients with Major Depressive Disorder Using the Voxel-based Specific Regional Aanalysis System for Alzheimer's Disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Recently, voxel-based morphometry (VBM) has become a popular tool for the early diagnosis of Alzheimer’s disease (AD). The voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD) is a clinically useful VBM technique that employs magnetic resonance imaging (MRI) to automatically detect the loss of Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation gray matter volume in the medial temporal lobe. Objective: To investigate the utility of VSRAD for differentiating between AD and major depressive disorder (MDD), and to identify the neuropathological differences between the two groups. Methods: The subjects included 18 patients with MDD (mean ± standard deviation: 74.8 ± 7.1 years, 4 males and 14 females) and 31 patients with AD (82.4 ± 7.3 years, 7 males and 24 females). Three-dimensional T1-weighted sagittal images, were acquired using a 1.5Tesla MRI device and analyzed using the VSRAD advance software, parahippocampal atrophy was represented as a Z-score. Neuropsychological tests consisted of the Patient Health Questionnaire 9, Hamilton Rating Scale for Depression, Global Assessment of Function and Mini-Mental State Examination (MMSE). Correlations between the Z-score and the neuropsychological test scores were statistically examined. Results: Patients with AD had significantly higher Z-scores than did patients with MDD (1.99 ± 1.27 vs. 1.11 ± 0.49, p 2 were all diagnosed as AD. In the AD group, the Z-scores were significantly correlated with the MMSE scores throughout the study period (0 weeks: p=0.015, 24 weeks: p=0.024), whereas no significant correlations between the Z-scores and MMSE were observed for the MDD group. Conclusion: Our results obtained using the VSRAD suggest that VSRAD is useful for differentiating between AD and MDD, which is important, as the these two diseases are often difficult to diagnose based solely on their symptoms. Such findings imply that VSRAD may become a useful auxiliary diagnostic tool.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Brain Disorders & Therapy.
Article · 10 Jun 2026
Brain Network Dysfunction: How Altered Neural Communication Affects Health
Article · 10 Jun 2026
Mitochondrial Encephalopathy: Understanding Energy Failure in the Nervous System
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBrain Disorders & Therapy
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Takahiro Tokumasu”
- BylineArticles whose byline prints “Yuka Okajima”
- BylineArticles whose byline prints “Osamu Takashio”
- BylineArticles whose byline prints “Masayuki Tani”
- BylineArticles whose byline prints “Takuji Izuno”
- BylineArticles whose byline prints “Daisuke Ikuse”
- BylineArticles whose byline prints “Teppei Morita”
- BylineArticles whose byline prints “Gosuke Arai”
